Clinical Trial NCT04747613

Trial

Novartis – CLNP023C12001B

Clinical trial ID

NCT04747613

Drug name

LNP023 Iptacopan

Company:

Novartis

Drug trade name

Fabhalta®

Phase of study

3

Current status

Recruiting

Start

07/2021

Substance

Low molecular compound

Research question

Long-term evaluation

Delivery method of drug

Oral

Frequency

2 x daily

Clinical trial locations

Brazil China Czechia France Germany Italy Japan Lithuania Malaysia Netherlands Singapore South Korea Spain Taiwan UK USA